Related Experiment Video
Updated: Jul 28, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation
D M Thomas1, S A Carty, D M Piscopo
1Department of Pathology and, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.
Abstract:
The incidence of osteosarcoma is increased 500-fold in patients who inherit mutations in the RB gene. To understand why the retinoblastoma protein (pRb) is specifically targeted in osteosarcoma, we studied its function in osteogenesis. Loss of pRb but not p107 or p130 blocks late osteoblast differentiation. pRb physically interacts with the osteoblast transcription factor, CBFA1, and associates with osteoblast-specific promoters in vivo in a CBFA1-dependent fashion. Association of pRb with CBFA1 and promoter sequences results in synergistic transactivation of an osteoblast-specific reporter. This transactivation function is lost in tumor-derived pRb mutants, underscoring a potential role in tumor suppression. Thus, pRb functions as a direct transcriptional coactivator promoting osteoblast differentiation, which may contribute to the targeting of pRb in osteosarcoma.
Insights
Retinoblastoma protein (pRb) loss blocks osteoblast differentiation, a key process in bone formation. This pRb function is crucial for suppressing osteosarcoma, a bone cancer.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Osteosarcoma incidence is significantly higher in patients with RB gene mutations.
- The retinoblastoma protein (pRb) is implicated in osteosarcoma pathogenesis.
- Understanding pRb's role in osteogenesis is crucial for explaining its specific targeting in osteosarcoma.
Purpose of the Study:
- To investigate the function of retinoblastoma protein (pRb) in osteogenesis.
- To determine why pRb is specifically targeted in osteosarcoma development.
Main Methods:
- Studied the effects of pRb loss on osteoblast differentiation.
- Investigated pRb's physical interactions with the transcription factor CBFA1.
- Analyzed pRb association with osteoblast-specific promoters in vivo.
- Assessed the transactivation function of pRb using reporter assays.
Main Results:
- Loss of pRb, but not p107 or p130, inhibits late osteoblast differentiation.
- pRb physically interacts with CBFA1 and binds to osteoblast promoters in a CBFA1-dependent manner.
- pRb and CBFA1 synergistically activate osteoblast-specific gene expression.
- Tumor-derived pRb mutants exhibit impaired transactivation function.
Conclusions:
- pRb acts as a direct transcriptional coactivator essential for osteoblast differentiation.
- The tumor suppressor function of pRb in osteogenesis may explain its targeting in osteosarcoma.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Co-activators and Co-repressors
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

